DIM
TMDX icon

DC Investments Management’s Transmedics TMDX Stock Holding History

DC Investments Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-26,834
Closed -$778K – 347
2019
Q2 		$778K Buy
+26,834
New +$733K 0.44% 23

Other funds holding TMDX

ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DC Investments Management's TMDX Position: Q3 2019 in Review

DC Investments Management sold out of Transmedics (TMDX) in Q3 2019, closing a stake of 26,834 shares — an estimated $778K sold.

DC Investments Management first reported a position in TMDX in Q2 2019 and held it in 1 quarter. The position peaked at $778K in Q2 2019. 50 funds tracked by Wall St. Rank hold TMDX as of Q3 2019.

  • DC Investments Management reported no remaining Transmedics position as of Q3 2019 after selling out during the quarter.
  • DC Investments Management sold 26,834 Transmedics shares in Q3 2019, an estimated $778K.
  • DC Investments Management first reported a position in Transmedics in Q2 2019 and held it in 1 quarter.
  • DC Investments Management's Transmedics position peaked at $778K in Q2 2019.
  • 50 funds tracked by Wall St. Rank held Transmedics as of Q3 2019.

Based on DC Investments Management's 13F filing for Q3 2019, filed 5 Nov 2019.